Analysis of Clinical Samples of Pancreatic Cyst's Lesions with A Multi‐Analyte Bioelectronic Simot Array Benchmarked Against Ultrasensitive Chemiluminescent Immunoassay (Adv. Sci. 27/2024)
Source abstract
Abstract
Liquid Biopsy Pancreatic cancer, ranked as the third-leading cause of cancer-related deaths, necessitates enhanced diagnostic measures through early detection. In response, SiMoT-single-molecule with a large transistor multiplexing array, achieving a technology readiness level of 5, is proposed in article number 2308141 by Eleonora Macchia, Luisa Torsi, and co-workers for timely identification of pancreatic cancer precursor cysts and is benchmarked against the commercially available chemiluminescent immunoassay single molecule array (SIMOA) SP-X system.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Microfluidic and Bio-sensing Technologies · 3D Printing in Biomedical Research · Microfluidic and Capillary Electrophoresis Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.